Systemic Pharmacokinetics of BOL-303224-A

Summary

This is a multi-center, open-label, single dose/multiple dose, pharmacokinetic study in participants with bacterial conjunctivitis. The purpose of this study is to determine the extent of systemic exposure to BOL-303224-A following single and multiple topical administration of BOL-303224-A in participants with suspected bacterial conjunctivitis.

Timeline

Start

2006-10

Primary completion

2007-10

Completion

2007-10

Drugs

Indications